KU-60019

Research use only, not for human use.

KU-60019 is an improved analogue of KU-55933, and is a potent, specific inhibitor of ATM kinase with IC50 of 6.3 nM, 270- and 1,600-fold selectivity over DNA-PKcs and ATR.

KU-60019 is an improved analogue of KU-55933, and is a potent, specific inhibitor of ATM kinase with IC50 of 6.3 nM, 270- and 1,600-fold selectivity over DNA-PKcs and ATR; blocks radiation-induced phosphorylation of key ATM targets in human glioma cells, which is 10-fold more effective than KU-55933, reduces basal S473 AKT phosphorylation and inhibits glioma cell migration and invasion in vitro; preferentially sensitizes p53-mutant glioma to ionizing radiation in orthotopic xenograft models of GBM.

——

——

KU60019 | KU 60019

Cell Cycle/DNA Damage

ATM/ATR

ATM/ATR

Cancer

——

925701-46-8

547.6651

C30H33N3O5S

>98% (HPLC)

DMSO: ≥ 30 mg/mL

CC1CN(CC(O1)C)CC(=O)NC2=CC3=C(C=C2)SC4=C(C3)C=CC=C4C5=CC(=O)C=C(O5)N6CCOCC6

4-Morpholineacetamide, 2,6-dimethyl-N-[5-[6-(4-morpholinyl)-4-oxo-4H-pyran-2-yl]-9H-thioxanthen-2-yl]-, (2R,6S)-rel-

(-20℃)

With Ice Pack

≥ 2 years